AR-R17779, an α7 nicotinic agonist, improves learning and memory in rats

Behavioural Pharmacology

Volumn 10, Issue 6-7, 1999, Pages 675-680

  Levin, Edward D ^a,c   Bettegowda, C ^a   Blosser, J ^b   Gordon, J ^b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b Astra Arcus USA   (United States)

^c DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Fimbria fornix lesions; Memory; Nicotinic; Radial arm maze; Rat; 7 nicotinic receptors

Indexed keywords

AR R 13489; NICOTINIC AGENT; NICOTINIC RECEPTOR; RECEPTOR SUBTYPE; SPIRO[1 AZABICYCLO[2.2.2]OCTANE 3,2' THIAZOLIDINE] 2' ONE; UNCLASSIFIED DRUG; ALPHA-BUNGAROTOXIN RECEPTOR; AR-R 17779; BRIDGED COMPOUND; BUNGAROTOXIN RECEPTOR; SPIRO COMPOUND;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN FORNIX; COGNITION; CONTROLLED STUDY; FEMALE; HIPPOCAMPUS; LEARNING; MAZE TEST; MEMORY; NERVE LESION; NONHUMAN; RACEMIC MIXTURE; RAT; TRAINING; WORKING MEMORY; ANIMAL; DRUG EFFECT; SHORT TERM MEMORY; SPRAGUE DAWLEY RAT;

ANIMALS; BRIDGED COMPOUNDS; FEMALE; LEARNING; MAZE LEARNING; MEMORY; MEMORY, SHORT-TERM; NICOTINIC AGONISTS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, NICOTINIC; SPIRO COMPOUNDS;

EID: 0033237390     PISSN: 09558810     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008877-199911000-00014     Document Type: Article

References (29)

1. Arendash GW, Sengstock GJ, Sanberg PR, Kem WR (1995). Improved learning and memory in aged rats with chronic administration of the nicotinic receptor agonist GTS-21. Brain Res 674:252-259.
2. Brioni JD, Decker MW, Sullivan JP, Arneric SP (1997). The pharmacology of (-)-nicotine and novel cholinergic channel modulators. Adv Pharmacol 37:153-214.
3. Decker MW, Brioni JD, Bannon AW, Arneric SP (1995). Diversity of neuronal nicotinic acetylcholine receptors: Lessons from behavior and implications for CNS therapeutics - minireview. Life Sci 56:545-570.
4. Felix R, Levin ED (1997). Nicotinic antagonist administration into the ventral hippocampus and spatial working memory in rats. Neuroscience 81:1009-1017.
5. Gordon J, Gurley DA, Tran O, Machulskis A, Zongrone J, Luhowskyi S et al. (1998). AR-R 17779: The first high affinity, subtype-selective full agonist at the rodent alpha7 nicotinic acetylcholine receptor (nAChR). Soc Neurosci Abs 24:832.
6. Gurley DA, Lanthorn T, Ryan T, Luhowskyj S, Gordon J (1998). Comparison of nicotine and the alpha 7-selective agonist AR-R 17779 on nAChR alpha7 expressed in xenopus oocytes. Soc Neurosci Abs 24:832.
7. Hunter BE, de Fiebre CM, Papke RL, Kem WR, Meyer EM (1994). A novel nicotinic agonist facilitates induction of long-term potentiation in the rat hippocampus. Neurosci Lett 168:130-134.
8. Jones GMM, Sahakian BJ, Levy R, Warburton DM, Gray JA (1992). Effects of acute subcutaneous nicotine on attention, information processing and short-term memory in Alzheimer's disease. Psychopharmacology 108:485-494.
9. Kaiser F, Hudzik T, Borrelli A, Awere S, Cramer C, Widzowski D (1998). AR-R 17779, a selective alpha-7 nicotinic agonist, has anxiolytic and sensory gating-enhancing properties and reduced nicotine-like side effects. Soc Neurosci Abs 24:832.
10. Levin ED, Torry D (1996). Acute and chronic nicotine effects on working memory in aged rats. Psychopharmacology 123:88-97.
11. Levin ED, Simon BB (1998). Nicotinic acetylcholine involvement in cognitive function in animals. Psychopharmacalogy 138:217-230.
12. Levin ED, Briggs SJ, Christopher NC, Rose JE (1993a). Chronic nicotinic stimulation and blockade effects on working memory. Behav Pharmacol 4:179-182.
13. Levin ED, Christopher NC, Briggs SJ, Rose JE (1993b). Chronic nicotine reverses working memory deficits caused by lesions of the fimbria or medial basalocortical projection. Cogn Brain Res 1:137-143.
14. 1 agonist and antagonist drugs. Psychopharmacology 127:25-30.
15. Levin ED, Conners CK, Sparrow E, Hinton SC, Erhardt D, Meck WH et al. (1996b). Nicotine effects on adults with attention-deficit hyperactivity disorder. Psychopharmacology 123:55-63.
16. Levin E, Wilson W, Rose J, McEvoy J (1996c). Nicotine-haloperidol interactions and cognitive performance in schizophrenics. Neuropsychopharmacology 15:429-436.
17. Levin ED, Bettegowda C, Gordon J, Blosser J (1998). AR-R 17779, an α7 nicotinic agonist improves learning and memory in rats. Soc Neurosci Abs 24:183.
18. Levin E, Bradley A, Sigurani N (1999). Hippocampal nicotinic receptors and memory function in rats. In: Fifth annual SRNT meeting, 5-7 March, San Diego, CA. Society for Research on Nicotine and Tobacco.
19. Li YX, King MA, Grimes J, Smith N, de Fiebre CM, Meyer EM (1999). alpha 7-Nicotinic receptor mediated protection against ethanol-induced cytotoxicity in PC12 cells. Brain Res 816:225-228.
20. Meyer EM, Tay ET, Papke RL, Meyers C, Huang GL, deFiebre CM (1997). 3-[2,4-dimethoxybenzylidene]anabaseine (DMXB) selectively activates rat alpha 7 receptors and improves memory-related behaviors in a mecamylamine-sensitive manner. Brain Research, 768:49-56.
21. Newhouse P, Potter A, Corwin J (1996). Effects of nicotinic cholinergic agents on cognitive functioning in Alzheimer's and Parkinson's disease. Drug Dev Res 38:278-289.
22. Paylor R, Nguyen M, Crawley JN, Patrick J, Beaudet A, Orr-Urtreger A (1998). alpha 7-Nicotinic receptor subunits are not necessary for hippocampal-dependent learning or sensorimotor gating: A behavioral characterization of Acra7-deficient mice. Learn Mem 5:302-316.
23. Pellegrino LJ, Pellegrino AS, Cushman AJ (1979). A Stereotaxic Atlas of the Rat Brain. New York: Plenum Press.
24. Sahakian B, Jones G, Levy R, Gray J, Warburton D (1989). The effects of nicotine on attention, information processing, and short-term memory in patients with dementia of Alzheimer type. Br J Psychiatry 154:797-800.
25. Shimohama S, Greenwald DL, Shafron DH, Akaika A, Maeda T, Kaneko S (1998). Nicotinic alpha 7 receptors protect against glutamate neurotoxicity and neuronal ischemic damage. Brain Res 779:214-225.
26. Stevens KE, Kem WR, Mahnir VM, Freedman R (1998). Selective alpha(7)-nicotinic agonists normalize inhibition of auditory response in DBA mice. Psychopharmacology 136:320-327.
27. White HK, Levin ED (1999). Chronic four week nicotine skin patch treatment effects on cognitive performance in Alzheimer's disease. Psychopharmacology 143:158-165.
28. Wilson AL, Langley LK, Monley J, Bauer T, Rottunda S, McFalls E et al. (1995a). Nicotine patches in Alzheimer's disease: pilot study on learning, memory, and safety. Pharmacol Biochem Behav 51:509-514.
29. Wilson AL, McCarten JR, Langley LK, Bauer T, Monley J, Rottunda S et al. (1995b). Transdermal nicotine administration in Alzheimer's disease: effects on cognition, behavior and cardiac function. In: Research Advances in Alzheimer's Disease and Related Disorders. Iqbal K, Mortimer JA, Winblad B, Wisniewski HM (editors). Chichester: John Wiley, pp. 305-314.